NCT05062226View on ClinicalTrials.gov

GMP Case Studies of Tolerance, Safety and Acceptability in PKU and TYR

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 16, 2020

Primary Completion Date

August 30, 2023

Study Completion Date

November 24, 2023

Conditions
PKUTyrosinemias
Interventions
DIETARY_SUPPLEMENT

PKU/TYR GMP Protein Substitute

After a 1-day baseline period during which patients will consume their usual protein substitute, each patient will receive one the case study product for 4 weeks (28 days).

Trial Locations (1)

Unknown

Bristol University Hospitals, Bristol

All Listed Sponsors
lead

Nutricia UK Ltd

INDUSTRY

NCT05062226 - GMP Case Studies of Tolerance, Safety and Acceptability in PKU and TYR | Biotech Hunter | Biotech Hunter